Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of Recombinant Porcine Factor VIII (FVIII) in Hemophilia and Inhibitors to FVIII

This study has been completed.
Sponsor:
Collaborator:
Biomeasure Inc, Ipsen Group
Information provided by:
Octagen Corporation
ClinicalTrials.gov Identifier:
NCT00245245
First received: October 25, 2005
Last updated: October 2, 2007
Last verified: October 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2007
  Estimated Primary Completion Date: No date given